Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines.

Abstract

Gemcitabine (2',2'-difluorodeoxycytidine) is a novel pyrimidine nucleoside drug with clinical efficacy in several common epithelial cancers. We have proposed that gemcitabine requires nucleoside transporter (NT) proteins to permeate the plasma membrane and to exhibit pharmacological activity. In humans, there are seven reported distinct NT activities… (More)

Topics

10 Figures and Tables

Slides referencing similar topics